Malaria Prevention during Pregnancy—Is There a Next Step Forward?
article has not abstract
Vyšlo v časopise:
Malaria Prevention during Pregnancy—Is There a Next Step Forward?. PLoS Med 11(9): e32767. doi:10.1371/journal.pmed.1001734
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001734
Souhrn
article has not abstract
Zdroje
1. WickramasuriyaGAW (1935) Some observations on malaria occuring in association with pregnancy. With special reference to the transplacental passage of parasites from the maternal to the foetal circulation. Br J Obstet Gynaecol 42: 816–834.
2. McGregorIA (1984) Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 33: 517–525.
3. SteketeeRW, WirimaJJ, BlolandPB, ChilimaB, MerminJH, et al. (1996) Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg55 (suppl 1)42–49.
4. ter KuileFO, PariseME, VerhoeffFH, UdhayakumarV, NewmanRD, et al. (2004) The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 71: 41–54.
5. GarnerP, BrabinB (1994) A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas. Bull World Health Organ 72: 89–99.
6. World Health Organization (1986) WHO Expert Committee on Malaria 18th report; WHO Technical Series No. 735: p58. Geneva: WHO.
7. BrabinBJ, GinnyM, AlpersM, BrabinL, EggelteT, et al. (1990) Failure of chloroquine prophylaxis for falciparum malaria in pregnant women in Madang, Papua New Guinea. Ann Trop Med Parasitol 84: 1–9.
8. SteketeeRW, WirimaJJ, SlutskerL, HeymannDL, BremanJG (1996) The problem of malaria and malaria control in pregnancy in sub-Saharan Africa. Am J Trop Med Hyg 55 (suppl 1)2–7.
9. World Health Organization (2012) Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine- Pyrimethamine (IPTp-SP). Updated WHO Policy Recommendation. Geneva: WHO. Available: http://www.who.int/malaria/iptp_sp_updated_policy_recommendation_en_102012.pdf. Accessed 15 August 2014.
10. SchultzLJ, SteketeeRW, MachesoA, KazembeP, ChitsuloL, et al. (1994) The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515–522.
11. NaidooI, RoperC (2013) Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malaria. Trends Parasitol 29: 505–515.
12. GonzálezR, Mombo-NgomaG, OuédraogoS, KakolwaMA, AbdullaS, et al. (2014) Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med 11: e1001733.
13. GonzálezR, DesaiM, MaceteE, OumaP, KakolwaMA, et al. (2014) Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. PLoS Med 11: e1001735.
14. NostenF, VincentiM, SimpsonJ, YeiP, ThwaiKL, et al. (1999) The effects of mefloquine treatment in pregnancy. Clin Infect Dis 28: 808–815.
15. ter KuileFO, van EijkAM, FillerSJ (2007) Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 297: 2603–2616.
16. KayentaoK, GarnerP, van EijkAM, NaidooI, RoperC, et al. (2013) Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA 309: 594–604.
17. TagborH, BruceJ, AgboM, GreenwoodB, ChandramohanD (2010) Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS ONE 5: e14425.
18. Medicines for Malaria Venture (2014) Medicines for Malaria Venture (MMV) Annual report 2013. Geneva: WHO. Available: http://www.mmv.org/newsroom/publications/annual-report-2013 Accessed 15 August 2014.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2014 Číslo 9
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
- Monitoring and Evaluating Progress towards Universal Health Coverage in Chile
- Malaria Prevention during Pregnancy—Is There a Next Step Forward?
- The PLOS “Monitoring Universal Health Coverage” Collection: Managing Expectations